Showing results (1811-1820 of 2,209) with videos related to
Sort By:
Pageof 221
Peerj|May 31, 2018
A brief introduction to mixed effects modelling and multi-model inference in ecologyXavier A Harrison, Lynda Donaldson, Maria Eugenia Correa-Cano, et al.Blood|February 26, 2000
Interleukin 5 regulates the isoform expression of its own receptor alpha-subunitJ Tavernier, J Van der Heyden, A Verhee, et al.Expert Review of Anticancer Therapy|January 29, 2021
A phase 1b clinical trial optimizing regulatory T cell depletion in combination with platinum-based chemotherapy in thoracic cancersAlistair M Cook, Alison McDonnell, Michael J Millward, et al.American Journal of Respiratory and Critical Care Medicine|November 1, 1996
IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: evidence against "intrinsic" asthma being a distinct immunopathologic entityM Humbert, S R Durham, S Ying, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2009
Locally administered TLR7 agonists drive systemic antitumor immune responses that are enhanced by anti-CD40 immunotherapySteve A Broomfield, Robbert G van der Most, Amy C Prosser, et al.Journal of Public Health Dentistry|May 13, 2010
Four "lessons learned" while implementing a multi-site caries prevention trialJames D Bader, Debbie S Robinson, Gregg H Gilbert, et al.The American Journal of Tropical Medicine and Hygiene|November 2, 2010
Evaluation of three commercially available Japanese encephalitis virus IgM enzyme-linked immunosorbent assaysJaimie S Robinson, David Featherstone, Ravi Vasanthapuram, et al.Molecular Biology of the Cell|November 1, 2016
p120-catenin regulates VE-cadherin endocytosis and degradation induced by the Kaposi sarcoma-associated ubiquitin ligase K5Benjamin A Nanes, Cynthia M Grimsley-Myers, Chantel M Cadwell, et al.The American Journal of Pathology|July 11, 2002
Molecular profiling of angiogenesis markersShu-Ching Shih, Gregory S Robinson, Carole A Perruzzi, et al.Journal of Medicinal Chemistry|January 21, 1994
Novel cAMP PDE III inhibitors: imidazo[4,5-b]pyridin-2(3H)-ones and thiazolo[4,5-b]pyridin-2(3H)-ones and their analogsB Singh, E R Bacon, S Robinson, et al.Pageof 221